|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tet- anus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine显示文摘 | Meriste S Lutsar I Tamm' E | 2006 | Scand J Infect Dis2006，38，5： | 1 |
| 2 | Safety of vorieonazole and dose individualization显示文摘 | LUTSAR I HODGES MR TOMASZEWSKI K | 2003 | Clin Infect Dis2003，36，8： | 1 |
| 3 | Voriconazole in the treatment of aspergillosis,scedosporiosis and other invasive fungal infections in children显示文摘 | Walsh TJ Lutsar I Driscoll T | | 0，，03： | 1 |
| 4 | Safety of voriconazole and dose individualization显示文摘 | Lutsar I Hodges M R Tomaszewski K | 2003 | Clin Infect Dis2003，36，8： | 1 |
| 5 | Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated pohovirus vaccine 显示文摘 | Meriste S Lutsar I Tamm E | 2006 | Scand J Infect Dis2006，38，5： | 1 |
| 6 | Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis显示文摘 | Friedland IR Wubbel L | 1998 | Antimicrob Agents Chemother1998，42，10： | 1 |
| 7 | Voriconazole in the treatment of aspergillosis, scedosporiosis, and other invasive fungal in fections in children显示文摘 | Walsh TJ Lutsar I Driscoll T | 2002 | Pediatr Infect Dis J2002，21，： | 1 |
| 8 | Enzymatic changes in the cerebrospinal fluid in patients with infections of the central nervous system 显示文摘 | Lutsar I Haldre S Topman M | 1994 | Acta Paediatr1994，83，11： | 1 |
| 9 | Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children 显示文摘 | Walsh TJ Lutsar I Driscoll T | 2002 | Pediatr Infect Dis J2002，21，3： | 1 |
| 10 | Pharmacodynamics of vancomycin for the treatment of experimental penicillin-and cephalosporin resistant pneumococcal meningitis显示文摘 | Ahmed A Jafri H Lutsar I | 2012 | Antimi crobial Agents Chemotherapy2012，43，12： | 1 |
| 11 | Safety of voriconazole and dose individualization 显示文摘 | LUTSAR I HODGES MR TOMASZEWSKI K | 2003 | Clin Infect Dis2003，36，8： | 1 |
| 12 | Efficacy of gatifloxacin experimental Escherichia colimeningitis 显示文摘 | Lutsar I Friedland IR Jafri HS | 1999 | Antimicrob Agents chemother1999，43，7： | 1 |
| 13 | Antibiotic pharmacodynamics in cerebrospinal fluid显示文摘 | Lutsar I Mc Cracken GH Jr Friedland IR | 1998 | Clin Infect Dis1998，27，： | 1 |
| 14 | Voriconazolefor invasive bone aspergillosis : a worldwide experience of 20 cases 显示文摘 | Mouas H Lutsar I Dupont B | 2005 | Clin Infeet Dis2005，40，8： | 1 |
| 15 | Pharmacodynaimcs of vancomycinfor the treatment of experimental penicillin- and cephalosporin-resistantpneumococcal meningitis 显示文摘 | Ahmed A Jafri H Lutsar I | 1999 | Antimicrob Agents Chemother1999，43，4： | 1 |
| 16 | Voriconazole for invasive bone aspergillosis : a worldwide experience of 20 cases 显示文摘 | MOUAS H LUTSAR I DUPONT B | 2005 | Clin Infect Dis2005，40，： | 1 |
| 17 | Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies显示文摘 | Karlsson MO Lutsar I Milligan PA | | 0，，3： | 1 |
| 18 | Population pharmaco- kinetic analysis of voriconazole plasma concentration data from pediatric studies显示文摘 | Karlsson MO Lutsar I Milligan PA | 2009 | Antimicrob Agents Chemother2009，53，3： | 1 |
| 19 | Epidemiological characteristics of pertussis in Estonia, Lith- uania, Romania, the Czech Republic, Poland and Turkey--1945 to 2005 显示文摘 | Lutsar I | 2009 | European Journal of Pediatrics2009，168，4： | 1 |
| 20 | Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis 显示文摘 | Lutsar I Ahmed A Frledland I R | 1997 | Antimicrob Agents Chemother1997，41，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员